INJECT SAFELY
EVERY 24 SECONDS
A PATIENT DIES FROM
A NEEDLE STICK*
44 Billion Injections/Year
DEATH DUE TO
A MISPLACED
INJECTION IS A
"NEVER EVENT"
indication of the presence or absence
of blood in a needle-based procedure.
We Take Pride in Our Leadership
Never Event Prevention
The National Quality Forum and Centers for Medicare define “Never Events” in health care as “errors in medical care that are clearly identifiable, preventable, and serious in their consequences for patients, and indicate a critical problem in safety and credibility of a health care facility.” Events which result in patient death or serious disability have been associated with an intravascular air embolism that occurs while being cared for in a healthcare facility in which a device is used for functions other than its intended purpose.
Other forms of inadvertent embolism cause similar harm. Local anesthetics injected into the vasculature can cause cardiac dysrhythmia and death, known as LAST- Local Anesthetic Toxicity Syndrome. Over 300 million dental procedures occur in the United States annually. When local anesthetic infused with epinephrine is introduced into the dental vasculature, preventable deaths may result. We at ACIES believe this fits National Quality Foundation and Medicare guidelines of a Never Event and we offer a solution of prevention.
Identify a "Never Event" before it ever happens. Get Acies.
Similarly, inadvertent intravascular mRNA vaccine injections, aka vaccine embolism, have a strong link to myocarditis. This article from the Oxford University Press describes the mechanisms in detail: https://www.ncbi.nlm.nih.gov/pmc/arti . France advised against the Moderna Vaccine for citizens Under-30 due to this risk. In a recent survey, only 18% of U.S. parents are willing to administer mRNA vaccine to their young children. The “Never Event” of vaccine embolism, which ACIES is designed to prevent, drives vaccine hesitancy, and is a major public health concern.
The Importance of Time
First invented in 1844, over 95% of radiologists agree that needles need to be improved for patient safety. The Acies Smart Needle luminesces on contact with blood, assuring the user of appropriate placement prior to an injection without the use of radiation, kidney damaging contrast dye, or user-dependent ultrasound.
There is a saying in the Emergency Room, that “Time is Heart” and “Time is Brain.” Obtaining rapid vascular access for trauma patients, cardiac patients, and stroke patients affects outcomes. In the case of a heart attack, taking longer than 55 minutes to initiate angioplasty, known as Door-to-Balloon-Time, increases the risk of death by 400%. Similarly for stroke, each minute delayed in evacuating a brain clot destroys over 7.5 miles (12.07km) of myelinated fiber in the brain. Patients can not afford delays due to the inability to obtain IV access.
From an economic perspective, delays in obtaining IV access create a tremendous cost, not only in terms of more complicated outcomes but also in lost revenue. At Medicare rates, which are a fraction of commercial insurance reimbursement, the opportunity cost of not performing an angioplasty is $ 250/minute at minimum.
COSTS:
Procedure
Reimbursement/Time
Opportunity & Overhead Costs
PTCA, Stent
$13,586/90 Minutes
$150/minute + $100/minute
Aortic Aneurysm
$43,489/90 Minutes
$483/minute + $100/minute
Peripheral Revascularization
$27,952/180 Minutes
$155/minute + $100/minute
Endovenous Embolization
$31,664/120 Minutes
$483/minute + $100/minute
Aortic Aneurysm
$31,664/120 Minutes
$263/minute + $100/minute
COSTS:
| Procedure | Reimbursement/Time | Opportunity & Overhead Costs |
|---|---|---|
| PTCA, Stent | $13,586/90 Minutes | $150/minute + $100/minute |
| Aortic Aneurysm | $43,489/90 Minutes | $483/minute + $100/minute |
| Peripheral Revascularization | $27,952/180 Minutes | $155/minute + $100/minute |
| Endovenous Embolization | $31,664/120 Minutes | $483/minute + $100/minute |
| Aortic Aneurysm | $31,664/120 Minutes | $263/minute + $100/minute |
Inadvertent Placement & Time to Access
If there is difficulty accessing two patients in the morning, and two in the afternoon for 10 minutes represents a minimum revenue loss of $10,000 per day, in excess of $2 Million annually, per cardiac catheterization and neurovascular labwork. We believe the value proposition for Acies in this scenario, both driving outcomes and lowering costs, is an ideal target market.
Assurance of appropriate placement is critical for central line placement to avoid lung puncture; for chemotherapy to eliminate subcutaneous delivery of caustic chemotherapeutic agents; in infusion therapy of costly immunotherapies as well as for neonatal and pediatric needle sticks.
In the Dental market, patients are at risk in the dental chair if the richly vascular gum tissue inadvertently absorbs anesthetics that are then delivered to the heart. While rare, cardiac dysrhythmia or death can occur. Death due to this type of inadvertent intravascular injection is a serious risk and referred to as a “Never Event”.
ACIES SMART NEEDLE IS NEEDED FOR MORE THAN JUST VACCINE APPLICATIONS
MULTIPLE
VERTICAL
MARKETS
THE LEADERSHIP TEAM
Dr. Daniel Sipple
Founder, Double Board Certified SBMT Global Think Tank
Jim Bracke, PhD
Microbiologist 39 Years Medical Science
Brian L. Norling
CTO, Inventor of Norlinium; owns 60+ Patents; Aerospace Consultant
Millimeters & Seconds
Drive Safety & Outcomes
Inadvertent Placement & Time to Access
STRATEGIC PARTNERSHIPS
Digital Marketing
Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des.
SEO Optimization
Nemo enim ipsam volupttem quia voluptas sit aspernatur aut odit aut fugit.
Product Research
Ducimus qui blanditiis praese ntium voluptatum deleniti atque corrupti quos.
